NOVATO, Calif. — NOVATO, Calif. — Ultragenyx Pharmaceutical Inc. on Thursday reported a lack of $151.8 million in its fourth quarter. The Novato, California-based company said it had a loss of $2.16 per share. BOSTON — BOSTON — DraftKings Inc. …
sohu.my.id